このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Boston Scientific マネジメント
マネジメント 基準チェック /34
Boston Scientific'sの CEO はMike Mahoneyで、 Oct2011年に任命され、 の在任期間は 12.67年です。 の年間総報酬は$ 18.72Mで、 7.5%給与と92.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.13%を直接所有しており、その価値は$ 146.21M 。経営陣と取締役会の平均在任期間はそれぞれ8.2年と8年です。
主要情報
Mike Mahoney
最高経営責任者
US$18.7m
報酬総額
| CEO給与比率 | 7.5% |
| CEO在任期間 | 12.9yrs |
| CEOの所有権 | 0.1% |
| 経営陣の平均在職期間 | 8.5yrs |
| 取締役会の平均在任期間 | 8.2yrs |
経営陣の近況
Recent updates
Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement
Sep 24
Boston Scientific: Forward Returns Are Likely To Be Disappointing For Investors
Sep 20Boston Scientific Corporation's (NYSE:BSX) P/E Still Appears To Be Reasonable
Sep 09A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Aug 23The Strong Earnings Posted By Boston Scientific (NYSE:BSX) Are A Good Indication Of The Strength Of The Business
Aug 08Boston Scientific Q2 Earnings Preview: Can The Rally Continue?
Jul 17Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching
Jul 05Should You Investigate Boston Scientific Corporation (NYSE:BSX) At US$77.00?
Jun 21Boston Scientific Has Become A Standout Growth Story In Med-Tech
Jun 13Why We're Not Concerned About Boston Scientific Corporation's (NYSE:BSX) Share Price
Jun 08Is Boston Scientific (NYSE:BSX) Using Too Much Debt?
May 10Boston Scientific (NYSE:BSX) Is Reinvesting At Lower Rates Of Return
Apr 22Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
Apr 05A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Mar 26We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease
Feb 29What You Can Learn From Boston Scientific Corporation's (NYSE:BSX) P/E
Feb 15Is Boston Scientific (NYSE:BSX) A Risky Investment?
Feb 02Boston Scientific (NYSE:BSX) Could Be Struggling To Allocate Capital
Jan 19Boston Scientific: Portfolio Updates Driving Top-Line Growth
Jan 17Boston Scientific: Continued M&A Drives More Growth
Jan 10Is Boston Scientific Corporation (NYSE:BSX) Worth US$56.1 Based On Its Intrinsic Value?
Dec 04Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet?
Nov 03Boston Scientific: Delivering Strong Growth, But Sector Derating Is A Big Issue
Oct 30ADVENT Offers Up An Early Present For Boston Scientific Investors
Aug 28Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
Aug 24Boston Scientific (NYSE:BSX) Seems To Use Debt Quite Sensibly
Jul 25Boston Scientific Remains Operationally Sound But May Have Limited Upside
Jul 14Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital
Jul 10Boston Scientific Corporation (NYSE:BSX) Shares Could Be 29% Above Their Intrinsic Value Estimate
May 21CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$19m | US$1m | US$2b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$861m |
| Mar 31 2023 | n/a | n/a | US$846m |
| Dec 31 2022 | US$17m | US$1m | US$642m |
| Sep 30 2022 | n/a | n/a | US$596m |
| Jun 30 2022 | n/a | n/a | US$828m |
| Mar 31 2022 | n/a | n/a | US$754m |
| Dec 31 2021 | US$16m | US$1m | US$985m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$526m |
| Mar 31 2021 | n/a | n/a | US$201m |
| Dec 31 2020 | US$14m | US$667k | -US$115m |
| Sep 30 2020 | n/a | n/a | US$4b |
| Jun 30 2020 | n/a | n/a | US$4b |
| Mar 31 2020 | n/a | n/a | US$4b |
| Dec 31 2019 | US$16m | US$1m | US$5b |
| Sep 30 2019 | n/a | n/a | US$1b |
| Jun 30 2019 | n/a | n/a | US$1b |
| Mar 31 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$14m | US$1m | US$2b |
| Sep 30 2018 | n/a | n/a | US$670m |
| Jun 30 2018 | n/a | n/a | US$521m |
| Mar 31 2018 | n/a | n/a | US$112m |
| Dec 31 2017 | US$13m | US$1m | US$104m |
報酬と市場: Mikeの 総報酬 ($USD 18.72M ) は、 US市場 ($USD 13.52M ) の同規模の企業の平均を上回っています。
報酬と収益: Mikeの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Mike Mahoney (59 yo)
12.9yrs
在職期間
US$18,723,735
報酬
Mr. Michael F. Mahoney, also known as Mike, has been Independent Director of CVS Health Corporation since November 01, 2023. He has been Chairman of Boston Scientific Corporation since May 3, 2016, and is...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 12.9yrs | US$18.72m | 0.12% $ 152.2m | |
| Executive VP & CFO | 10.7yrs | US$5.83m | 0.015% $ 18.6m | |
| Executive VP & Group President of Cardiology | 14.6yrs | US$5.59m | 0.012% $ 15.1m | |
| Executive VP & President of Peripheral Interventions | 11.7yrs | US$3.78m | 0.0019% $ 2.3m | |
| Executive VP and Group President of MedSurg & Asia Pacific | 8.2yrs | US$4.27m | 0.0016% $ 2.0m | |
| Executive Vice President of Global Operations | 2.3yrs | データなし | 0.0036% $ 4.4m | |
| Senior VP | less than a year | データなし | 0.00026% $ 318.1k | |
| Senior VP and Chief Information & Digital Officer | 8.8yrs | データなし | データなし | |
| Senior VP of Investor Relations | less than a year | データなし | 0.0026% $ 3.2m | |
| Senior VP | 3.3yrs | データなし | 0.0023% $ 2.9m | |
| Senior VP of Market Access & Chief Marketing Officer | 3.3yrs | データなし | データなし | |
| Executive Vice President of Human Resources | 11.8yrs | データなし | 0.0025% $ 3.1m |
8.5yrs
平均在職期間
56yo
平均年齢
経験豊富な経営陣: BSXの経営陣は経験豊富で経験豊富です（平均在職期間は8.2年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 11.8yrs | US$18.72m | 0.12% $ 152.2m | |
| Lead Independent Director | 10.5yrs | US$360.00k | 0.0030% $ 3.7m | |
| Independent Director | 8.4yrs | US$335.00k | 0.0033% $ 4.0m | |
| Independent Director | 8.2yrs | US$320.00k | 0.00020% $ 244.7k | |
| Independent Director | 3.3yrs | US$338.75k | 0.0027% $ 3.3m | |
| Director | less than a year | データなし | データなし | |
| Director | less than a year | データなし | 0.00024% $ 293.6k | |
| Independent Director | 9.4yrs | US$326.25k | 0.0043% $ 5.2m | |
| Independent Director | 15.4yrs | US$340.00k | 0.0036% $ 4.4m | |
| Independent Director | 1.3yrs | US$233.23k | 0.00042% $ 513.9k | |
| Independent Director | 1.3yrs | US$233.23k | 0.00027% $ 330.3k |
8.2yrs
平均在職期間
60.5yo
平均年齢
経験豊富なボード: BSXの 取締役会 は 経験豊富 であると考えられます ( 8年の平均在任期間)。